Overview

Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops

Status:
Withdrawn
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the effectiveness of rizatriptan for treating attacks of chronic post-traumatic headache.
Phase:
N/A
Details
Lead Sponsor:
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan